Nika Pharmaceuticals, Inc
NIKA· OTC
NIKANika Pharmaceuticals, Inc
Filed May 12, 2022 · 10-Q · 42 days after period end · 0001826466-22-000057
| Metric | Q1 2022 | Q1 2021 |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | -$6.32K | -$5.75K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nika Pharmaceuticals, Inc · CIK 1145604 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 12, 2022 · 42 d after period end
